IRulya Therapeutics, Inc. (IRLA)
29.31
-2.36
(-7.45%)
USD |
NASDAQ |
Nov 05, 16:00
29.73
+0.42
(+1.43%)
After-Hours: 20:00
IRulya Therapeutics SG&A Expense (TTM) : 27.81M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.81M |
| March 31, 2026 | 14.52M |
| December 31, 2025 | 15.05M |
| September 30, 2025 | 15.70M |
| June 30, 2025 | 16.04M |
| March 31, 2025 | 17.40M |
| December 31, 2024 | 17.58M |
| September 30, 2024 | 18.20M |
| June 30, 2024 | 19.24M |
| March 31, 2024 | 18.77M |
| December 31, 2023 | 17.63M |
| September 30, 2023 | 16.27M |
| June 30, 2023 | 15.95M |
| March 31, 2023 | 20.78M |
| December 31, 2022 | 26.06M |
| September 30, 2022 | 30.84M |
| Date | Value |
|---|---|
| June 30, 2022 | 34.14M |
| March 31, 2022 | 32.14M |
| December 31, 2021 | 29.52M |
| September 30, 2021 | 26.19M |
| June 30, 2021 | 23.48M |
| March 31, 2021 | 20.60M |
| December 31, 2020 | 17.59M |
| September 30, 2020 | 15.51M |
| June 30, 2020 | 12.90M |
| March 31, 2020 | 11.18M |
| December 31, 2019 | 8.954M |
| September 30, 2019 | 6.032M |
| June 30, 2019 | 4.063M |
| March 31, 2019 | 1.597M |
| June 30, 2018 | 0.347M |
| March 31, 2018 | 0.347M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Korsana Biosciences, Inc. | 7.127M |
| PepGen Inc. | 23.44M |
| Q32 Bio, Inc. | 13.91M |
| Bridgebio Oncology Therapeutics, Inc. | 36.80M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |